Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

AstraZeneca, SSP, Tritax: What brokers said

SSP Group plc (LSE:SSPG)’s acquisition of Airport Retail Enterprises (ARE) in Australia should add 3% to group revenue and give it entry into four new airports in the country, says broker Jefferies,

Post completion, SSP will operate around 100 units across 11 of the largest 19 airports in Australia.

Read more

AstraZeneca PLC (LSE:AZN) was among the FTSE 100’s big fallers on Monday as debate raged on around the company’s year-end earnings late last week.

AstraZeneca found itself still reeling from what the market deemed disappointing earnings, with brokers having punished the pharmaceuticals giant over an unchanged dividend and lack of research and development newsflow.

Read more

Stifel remained cautious about the prospects of Tritax Big Box REIT PLC (LSE:BBOX)’s £924m all-paper deal for UK Commercial Property REIT (LSE:UKCM) (UKCM) announced this Monday.

The prospective NAV-for-NAV merger, which values UKCM at a 10.7% premium to last Friday’s closing price, would create the fourth-largest REIT in the UK with a £3.9 billion market capitalisation.

Read more

Ecora Resources has received a significant boost from a financing deal struck by Capstone Copper, says broker Peel Hunt.

Part of the C$431 million raised has been earmarked for the Santa Domingo project, where Ecora has a 2% royalty in production or development.

Read more

Equities analysts at Cavendish took notice of an eye-catching piece of research on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF)’s flagship immunotherapy asset today.

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) hailed research indicating a market opportunity exceeding $10 billion POLB 001, which has the potential to combat a common side-effect of cancer immunotherapy treatments.

Read more

A merger between real estate investment trusts (REITs) Tritax Big Box REIT PLC (LSE:BBOX) and UK Commercial Property (UKCM) could pave the way for more mergers in the sector.

That’s according to RBC Brewin Dolphin analysts, who noted that the £924 million all-paper bid from Tritax to create the UK’s fourth-largest REIT would help bring British trusts in line with larger peers across the Atlantic.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK